Long-term use requires periodic blood tests to monitor copper levels
Maintenance dosing for tirzepatide often settles at 5-10 mg for users who reached peak weight loss at higher doses, though the optimal maintenance dose is highly individual
There's no down time, and you can resume your usual activities immediately
Emerging evidencestrengthened by ASCO GI 2026suggests that GLP-1 receptor agonists may define the next era by addressing the metabolic roots of colorectal carcinogenesis
Austin K, Imam NA, Pintar JE, Brubaker PL
Description IGF-1 LR3 (Long [Arg] Insulin-like Growth Factor-1) is a recombinant synthetic analog of human insulin-like growth factor 1, engineered with two structural modifications: an arginine substitution replacing glutamate at position 3 of the IGF-1 sequence (reducing IGFBP-3 binding affinity), and a 13-amino-acid N-terminal extension (Long peptide leader)